Annual Lung SPORE Workshop (Abstract Submission)

Filter submissions
75 submissions
Created First Name Last Name Email Phone Select a Session Topic Abstract Title First Author First Name First Author Last Name Affiliation List of Additional Authors Your Abstract Submission Upload Abstract Special Characters Included? Abstract Review Status Upload Poster Poster Uploaded Operations
Mon, 03/11/2024 - 12:15 Elisabeth Martinez elisabeth.martinez@utsouthwestern.edu Session 4: Small Cell Lung Cancer Jumonji Histone Demethylases are Therapeutic Targets in Small Cell Lung Cancer Aiden Nguyen UTSW
  • First Name: Clarissa
    Last Name: Nunez
    Affiliation: UTSW
  • First Name: Tram Anh
    Last Name: Tran
    Affiliation: UTSW
  • First Name: John
    Last Name: Minna
    Affiliation: UTSW
  • First Name: Elisabeth
    Last Name: Martinez
    Affiliation: UTSW
 Abstract_Submission.pdf No Approved to be a Speaker
Sun, 03/10/2024 - 17:40 Jia Luo jia_luo@dfci.harvard.edu 6176323000 Session 1: Oncogene-driven lung cancers and resistance to targeted therapies Clinicopathologic and genomic features of patients with mucinous lung adenocarcinoma and response to systemic therapies Alessandro Di Federico DFCI
  • First Name: Lingzhi
    Last Name: Hong
    Affiliation: MDACC
  • First Name: Arielle
    Last Name: Elkrief
    Affiliation: MSKCC
  • First Name: Rohit
    Last Name: Thummalapalli
    Affiliation: MSKCC
  • First Name: Biagio
    Last Name: Ricciuti
    Affiliation: DFCI
  • First Name: Joao
    Last Name: Alessi
    Affiliation: DFCI
  • First Name: Pooja
    Last Name: Gogia
    Affiliation: MSKCC
  • First Name: Federica
    Last Name: Pecci
    Affiliation: DFCI
  • First Name: Malini
    Last Name: Gandhi
    Affiliation: DFCI
  • First Name: Marc
    Last Name: Ladanyi
    Affiliation: MSKCC
  • First Name: Jianjun
    Last Name: Zhang
    Affiliation: MDACC
  • First Name: Don
    Last Name: Gibbons
    Affiliation: MDACC
  • First Name: John
    Last Name: Heymach
    Affiliation: MDACC
  • First Name: Mizuki
    Last Name: Nishino
    Affiliation: DFCI
  • First Name: Lynette
    Last Name: Sholl
    Affiliation: BWH
  • First Name: Mark
    Last Name: Awad
    Affiliation: DFCI
  • First Name: Kathryn
    Last Name: Arbour
    Affiliation: MSKCC
  • First Name: Adam
    Last Name: Schoenfeld
    Affiliation: MSKCC
  • First Name: Natalie
    Last Name: Vokes
    Affiliation: MDACC
  • First Name: Jia
    Last Name: Luo
    Affiliation: DFCI
 Abstract_Submission.pdf No Approved to be a Poster Presenter
Thu, 03/14/2024 - 01:26 Alexandra Potter apotter8@mgh.harvard.edu 2538829777 Session 2: Health Disparities in Lung Cancer The Impact of Removing the 15-year Since Quitting Smoking Criterion on Lung Cancer Screening Eligibility Alexandra Potter Massachusetts General Hospital
  • First Name: Priyanka
    Last Name: Senthil
    Affiliation: Massachusetts General Hospital
  • First Name: Quiana
    Last Name: Guo
    Affiliation: Massachusetts General Hospital
  • First Name: Arian
    Last Name: Mansur
    Affiliation: Massachusetts General Hospital
  • First Name: Uma
    Last Name: Sachdeva
    Affiliation: Massachusetts General Hospital
  • First Name: Hugh
    Last Name: Auchincloss
    Affiliation: Massachusetts General Hospital
  • First Name: Chi-Fu Jeffrey
    Last Name: Yang
    Affiliation: Massachusetts General Hospital
 Abstract_Submission.pdf No Approved to be a Speaker
Sun, 03/10/2024 - 20:25 Alice Berger ahberger@fredhutch.org 2066676281 Session 1: Oncogene-driven lung cancers and resistance to targeted therapies Systematic discovery of osimertinib resistance variants using CRISPR prime editing Alice Berger Fred Hutch Abstract_Submission.pdf No Approved to be a Speaker
Mon, 03/11/2024 - 13:38 Robert Matera robert.matera@yale.edu Session 4: Small Cell Lung Cancer Longitudinal tumor microenvironment analysis in dual checkpoint inhibitor blockade using ipilimumab/nivolumab in patients with advanced stage small cell lung cancer Anne Chiang Yale University / Smilow Cancer Center
  • First Name: Robert
    Last Name: Matera
    Affiliation: Yale University / Smilow Cancer Center
  • First Name: Kerryan
    Last Name: Ashley
    Affiliation: Yale University / Smilow Cancer Center
  • First Name: Barani
    Last Name: Kumar
    Affiliation: Yale University / Smilow Cancer Center
  • First Name: Scott
    Last Name: Gettinger
    Affiliation: Yale University / Smilow Cancer Center
  • First Name: Sarah
    Last Name: Goldberg
    Affiliation: Yale University / Smilow Cancer Center
  • First Name: Roy
    Last Name: Herbst
    Affiliation: Yale University / Smilow Cancer Center
  • First Name: Frederick
    Last Name: Wilson
    Affiliation: Yale University / Smilow Cancer Center
  • First Name: Kurt
    Last Name: Schalper
    Affiliation: Yale University / Smilow Cancer Center and Yale Department of Pathology
 Abstract_Submission.pdf No Approved to be a Poster Presenter
Mon, 03/11/2024 - 13:09 Arnaud Augert arnaud.augert@yale.edu Session 4: Small Cell Lung Cancer The chromatin remodeling complex PBAF functions as a bona fide tumor suppressor complex in SCLC Arnaud Augert Yale University Abstract_Submission.pdf No Approved to be a Speaker
Mon, 03/11/2024 - 14:46 Austin Draycott austin.draycott@yale.edu 3475969754 Session 1: Oncogene-driven lung cancers and resistance to targeted therapies Dihydrouridine synthase 2 sustains levels of tRNACys to inhibit ferroptosis in lung cancer Austin Draycott Yale University
  • First Name: Matthew
    Last Name: Wang
    Affiliation: Yale University
  • First Name: Diana
    Last Name: Martínez Saucedo
    Affiliation: Yale University
  • First Name: Luisa
    Last Name: Escobar-Hoyos
    Affiliation: Yale University
  • First Name: Wendy
    Last Name: Gilbert
    Affiliation: Yale University
 Abstract_Submission.pdf No Approved to be a Poster Presenter
Thu, 02/29/2024 - 15:57 Bluma Lesch bluma.lesch@yale.edu 203-737-1074 Session 6: Cancer Biology Mechanisms of epigenetic sensitization to lung cancer risk Benjamin Walters Yale University
  • First Name: Jianlei
    Last Name: Gu
    Affiliation: Yale University
 Abstract_Submission.pdf No Approved to be a Poster Presenter
Mon, 03/11/2024 - 12:01 Mark Lee mark.n.lee@yale.edu 6178200262 Session 3: Immuno-oncology The antigen specificity of tumor-targeting T cells in non-small cell lung cancer Berkay Yahsi Yale Department of Laboratory Medicine
  • First Name: Benjamin
    Last Name: Lu
    Affiliation: Yale Cancer Center
  • First Name: Jianlei
    Last Name: Gu
    Affiliation: Yale School of Public Health
  • First Name: Kalyn
    Last Name: Whitehead
    Affiliation: Yale Department of Laboratory Medicine
  • First Name: Heather
    Last Name: Lazowski
    Affiliation: Yale Cancer Center
  • First Name: Yalai
    Last Name: Bai
    Affiliation: Yale Department of Pathology
  • First Name: David
    Last Name: Rimm
    Affiliation: Yale Department of Pathology
  • First Name: Hongyu
    Last Name: Zhao
    Affiliation: Yale School of Public Health
  • First Name: Veronica
    Last Name: Chiang
    Affiliation: Yale Department of Neurosurgery
  • First Name: David
    Last Name: Hafler
    Affiliation: Yale Department of Neurology
  • First Name: Kurt
    Last Name: Schalper
    Affiliation: Yale Department of Pathology
  • First Name: Mark
    Last Name: Lee
    Affiliation: Yale Department of Laboratory Medicine
 Abstract_Submission.pdf No Approved to be a Poster Presenter
Fri, 03/08/2024 - 21:20 Michael Oh michaeloh@mednet.ucla.edu 7169829966 Session 3: Immuno-oncology Phase I trial of intratumoral administration of autologous CCL21 gene-modified dendritic cells combined with pembrolizumab reveals local and systemic immune activation in advanced NSCLC Bin Liu UCLA
  • First Name: Aaron
    Last Name: Lisberg
    Affiliation: UCLA
  • First Name: Michael
    Last Name: Oh
    Affiliation: UCLA
  • First Name: Ramin
    Last Name: Salehi-Rad
    Affiliation: UCLA and VA Greater Los Angeles Health Care Center
  • First Name: Linh
    Last Name: Tran
    Affiliation: UCLA and VA Greater Los Angeles Health Care Center
  • First Name: Raymond
    Last Name: Lim
    Affiliation: UCLA
  • First Name: Camelia
    Last Name: Dumitras
    Affiliation: UCLA
  • First Name: Zhe
    Last Name: Jing
    Affiliation: UCLA
  • First Name: Fereidoun
    Last Name: Abtin
    Affiliation: UCLA
  • First Name: Robert
    Last Name: Suh
    Affiliation: UCLA
  • First Name: Scott
    Last Name: Genshaft
    Affiliation: UCLA
  • First Name: Scott
    Last Name: Oh
    Affiliation: UCLA
  • First Name: Gregory
    Last Name: Fishbein
    Affiliation: UCLA
  • First Name: Anita
    Last Name: Kaul
    Affiliation: UCLA
  • First Name: Kanwarpal
    Last Name: Kahlon
    Affiliation: UCLA
  • First Name: Shahryar
    Last Name: Ashouri
    Affiliation: UCLA
  • First Name: Jay
    Last Name: Lee
    Affiliation: UCLA
  • First Name: Kostyantyn
    Last Name: Krysan
    Affiliation: UCLA and VA Greater Los Angeles Health Care Center
  • First Name: Jonathan
    Last Name: Goldman
    Affiliation: UCLA
  • First Name: David
    Last Name: Elashoff
    Affiliation: UCLA
  • First Name: Edward
    Last Name: Garon
    Affiliation: UCLA
  • First Name: Steven
    Last Name: Dubinett
    Affiliation: UCLA and VA Greater Los Angeles Health Care Center
 Abstract_Submission.pdf No Approved to be a Poster Presenter
Fri, 03/08/2024 - 19:37 Boning Gao boning.gao@utsouthwestern.edu 2146484915 Session 6: Cancer Biology New human cell line models for the study of pathogenesis of SARS-CoV-2 infection Boning Gao UT Southwestern
  • First Name: Ian
    Last Name: Boys
    Affiliation: UT Southwestern
  • First Name: Sara
    Last Name: El Zahed
    Affiliation: Icahn School of Medicine at Mount Sinai
  • First Name: Kimberley
    Last Name: Avila
    Affiliation: UT Southwestern
  • First Name: Long Shan
    Last Name: Li
    Affiliation: UT Southwestern
  • First Name: Luc
    Last Name: Girard
    Affiliation: UT Southwestern
  • First Name: Hyunsil
    Last Name: Park
    Affiliation: UT Southwestern
  • First Name: Victor
    Last Name: Stastny
    Affiliation: UT Southwestern
  • First Name: Kenneth
    Last Name: Huffman
    Affiliation: UT Southwestern
  • First Name: Shreoshi Pal
    Last Name: Choudhuri
    Affiliation: UT Southwestern
  • First Name: Kimberly
    Last Name: Batten
    Affiliation: UT Southwestern
  • First Name: Matthew
    Last Name: Esparza
    Affiliation: UT Southwestern
  • First Name: Benjamin
    Last Name: Drapkin
    Affiliation: UT Southwestern
  • First Name: Lisa
    Last Name: Miorin
    Affiliation: Icahn School of Medicine at Mount Sinai
  • First Name: Jerry
    Last Name: Shay
    Affiliation: UT Southwestern
  • First Name: Wendy
    Last Name: Maury
    Affiliation: University of Iowa
  • First Name: Beatriz
    Last Name: Fontoura
    Affiliation: UT Southwestern
  • First Name: John
    Last Name: Schoggins
    Affiliation: UT Southwestern
  • First Name: Adolfo
    Last Name: Garcia-Sastre
    Affiliation: Icahn School of Medicine at Mount Sinai
  • First Name: John
    Last Name: Minna
    Affiliation: UT Southwestern
 Abstract_Submission.pdf No Approved to be a Poster Presenter
Sun, 03/10/2024 - 20:03 Caro Kravitz caro.kravitz@yale.edu Session 6: Cancer Biology The lysine demethylase KDM2A regulates tumor cell clustering to potentiate metastasis Caro Kravitz Yale University
  • First Name: Kiran
    Last Name: Patel
    Affiliation: Yale
  • First Name: Wesley
    Last Name: Cai
    Affiliation: Yale
  • First Name: Anna
    Last Name: Arnal-Estapé
    Affiliation: Yale
  • First Name: Dejian
    Last Name: Zhao
    Affiliation: Yale
  • First Name: Emily
    Last Name: Wingrove
    Affiliation: Yale
  • First Name: Laura
    Last Name: Stevens
    Affiliation: Yale
  • First Name: Thomas
    Last Name: Westbrook
    Affiliation: Baylor
  • First Name: Qin
    Last Name: Yan
    Affiliation: Yale
  • First Name: Don
    Last Name: Nguyen
    Affiliation: Yale
 Abstract_Submission.pdf No Approved to be a Poster Presenter
Sun, 03/10/2024 - 03:47 Catherine Meador cbmeador@mgh.harvard.edu 9192603477 Session 4: Small Cell Lung Cancer Detecting small cell transformation in patients with advanced EGFR mutant lung adenocarcinoma through epigenomic cfDNA profiling Catherine Meador Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
  • First Name: Talal
    Last Name: El Zarif
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Xintao
    Last Name: Qiu
    Affiliation: Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Ji-Heui
    Last Name: Seo
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Matthew
    Last Name: Davidsohn
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Hunter
    Last Name: Savignano
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Gitanjali
    Last Name: Lakshminaranan
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Heather
    Last Name: McClure
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: John
    Last Name: Canniff
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Brad
    Last Name: Fortunato
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Rong
    Last Name: Li
    Affiliation: Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Mandeep
    Last Name: Banwait
    Affiliation: Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
  • First Name: Karl
    Last Name: Semaan
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Marc
    Last Name: Eid
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Henry
    Last Name: Long
    Affiliation: Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Yin
    Last Name: Hung
    Affiliation: Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
  • First Name: Navin
    Last Name: Mahadevan
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: David
    Last Name: Barbie
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Matthew
    Last Name: Oser
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Zofia
    Last Name: Piotrowska
    Affiliation: Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
  • First Name: Toni
    Last Name: Choueiri
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Sylvan
    Last Name: Baca
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Aaron
    Last Name: Hata
    Affiliation: Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
  • First Name: Matthew
    Last Name: Freedman
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Jacob
    Last Name: Berchuck
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
Abstract_Submission.pdf No Approved to be a Poster Presenter
Mon, 03/11/2024 - 00:35 Jianfeng Li jianfeng.li@emory.edu (412) 973-4647 Session 3: Immuno-oncology Uncovering the rewired IAP-JAK regulatory axis as an immune-dependent vulnerability of LKB1-mutant lung cancer Changfa Shu Department of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, GA 30322, USA
  • First Name: Jianfeng
    Last Name: Li
    Affiliation: Department of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, GA 30322, USA
  • First Name: Rui
    Last Name: Jin
    Affiliation: Department of Hematology and Medical Oncology, Emory University, Atlanta, GA 30322, USA
  • First Name: Dacheng
    Last Name: Fan
    Affiliation: Department of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, GA 30322, USA
  • First Name: Qiankun
    Last Name: Niu
    Affiliation: Department of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, GA 30322, USA
  • First Name: Danielle
    Last Name: Cicka
    Affiliation: Department of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, GA 30322, USA
  • First Name: Sean
    Last Name: Doyle
    Affiliation: Department of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, GA 30322, USA
  • First Name: Alafate
    Last Name: Wahafu
    Affiliation: Department of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, GA 30322, USA
  • First Name: Xi
    Last Name: Zheng
    Affiliation: Department of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, GA 30322, USA
  • First Name: Yuhong
    Last Name: Du
    Affiliation: Department of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, GA 30322, USA
  • First Name: Andrey A.
    Last Name: Ivanov
    Affiliation: Department of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, GA 30322, USA
  • First Name: Deon B
    Last Name: Doxie
    Affiliation: Department of Hematology and Medical Oncology, Emory University, Atlanta, GA 30322, USA
  • First Name: Kavita M
    Last Name: Dhodapkar
    Affiliation: Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University, Atlanta, GA, USA
  • First Name: Jennifer
    Last Name: Carlisle
    Affiliation: Department of Hematology and Medical Oncology, Emory University, Atlanta, GA 30322, USA
  • First Name: Taofeek
    Last Name: Owonikoko
    Affiliation: Department of Hematology and Medical Oncology, Emory University, Atlanta, GA 30322, USA
  • First Name: Gabriel
    Last Name: Sica
    Affiliation: Winship Cancer Institute of Emory University, Atlanta, GA 30322, USA
  • First Name: Yuan
    Last Name: Liu
    Affiliation: Winship Cancer Institute of Emory University, Atlanta, GA 30322, USA
  • First Name: Suresh
    Last Name: Ramalingam
    Affiliation: Department of Hematology and Medical Oncology, Emory University, Atlanta, GA 30322, USA
  • First Name: Madhav V
    Last Name: Dhodapkar
    Affiliation: Department of Hematology and Medical Oncology, Emory University, Atlanta, GA 30322, USA
  • First Name: Wei
    Last Name: Zhou
    Affiliation: Department of Hematology and Medical Oncology, Emory University, Atlanta, GA 30322, USA
  • First Name: Xiulei
    Last Name: Mo
    Affiliation: Department of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, GA 30322, USA
  • First Name: Haian
    Last Name: Fu
 Abstract_Submission.pdf No Approved to be a Speaker
Mon, 03/11/2024 - 13:33 Darin Dolezal darin.dolezal@yale.edu 203-584-4276 Session 6: Cancer Biology Brain metastasis Fibrosis Predicts Clinical Outcomes and Response to Treatment in Patients with Non-Small Cell Lung Cancer Darin Dolezal Yale School of Medicine - Department of Pathology
  • First Name: Sampada
    Last Name: Chande
    Affiliation: Yale School of Medicine
  • First Name: Anna
    Last Name: Arnal Estapé
    Affiliation: Yale School of Medicine
  • First Name: Sarah
    Last Name: Goldberg
    Affiliation: Yale School of Medicine
  • First Name: Declan
    Last Name: McGuone
    Affiliation: Yale School of Medicine
  • First Name: Veronica
    Last Name: Chiang
    Affiliation: Yale School of Medicine
  • First Name: Don
    Last Name: Nguyen
    Affiliation: Yale School of Medicine
 Abstract_Submission.pdf Yes Approved to be a Poster Presenter
Sun, 03/10/2024 - 20:25 Diane Yang dyang17@mgh.harvard.edu Session 6: Cancer Biology Profiling the protein interactome through cysteine-reactive libraries has revealed the identification of EML4ALK dimerizers Diane Yang Department of Pathology, Massachusetts General Hospital, Boston, MA
  • First Name: Stefan
    Last Name: Harry
    Affiliation: Center for Cancer Research, Massachusetts General Hospital, Boston, MA
  • First Name: Elizabeth
    Last Name: Codd
    Affiliation: Department of Pathology, Massachusetts General Hospital, Boston, MA
  • First Name: Stefan
    Last Name: Kaluziak
    Affiliation: Department of Pathology, Massachusetts General Hospital, Boston, MA
  • First Name: Edwin
    Last Name: Zhang
    Affiliation: Department of Pathology, Massachusetts General Hospital, Boston, MA
  • First Name: Alexander Daniel
    Last Name: Carlin
    Affiliation: Center for Cancer Research, Massachusetts General Hospital, Boston, MA
  • First Name: Zavontae
    Last Name: Oppong-Holmes
    Affiliation: Department of Pathology, Massachusetts General Hospital, Boston, MA
  • First Name: Wendy
    Last Name: Yang
    Affiliation: Department of Pathology, Massachusetts General Hospital, Boston, MA
  • First Name: Abigail
    Last Name: Smith
    Affiliation: Center for Cancer Research, Massachusetts General Hospital, Boston, MA
  • First Name: Dawn
    Last Name: Mitchell
    Affiliation: Department of Pathology, Massachusetts General Hospital, Boston, MA
  • First Name: Mariko
    Last Name: Hara
    Affiliation: Center for Cancer Research, Massachusetts General Hospital, Boston, MA
  • First Name: Siwen
    Last Name: Zhang
    Affiliation: Center for Cancer Research, Massachusetts General Hospital, Boston, MA
  • First Name: Harrison Byron
    Last Name: Chong
    Affiliation: Center for Cancer Research, Massachusetts General Hospital, Boston, MA
  • First Name: Maristela
    Last Name: Onozato
    Affiliation: Department of Pathology, Massachusetts General Hospital, Boston, MA
  • First Name: Liron
    Last Name: Bar-Peled
    Affiliation: Center for Cancer Research, Massachusetts General Hospital, Boston, MA
  • First Name: A. John
    Last Name: Iafrate
    Affiliation: Department of Pathology, Massachusetts General Hospital, Boston, MA
 Abstract_Submission.pdf No Approved to be a Poster Presenter
Mon, 03/11/2024 - 10:46 Don Nguyen don.nguyen@yale.edu Session 1: Oncogene-driven lung cancers and resistance to targeted therapies The ATM Kinase as a Therapeutic Target in Drug Resistant NSCLC with Brain Metastasis Don Nguyen Yale School of Medicine Abstract_Submission.pdf No Approved to be a Speaker
Mon, 03/11/2024 - 14:55 Elda Railey erailey@researchadvocacy.org 2146839937 Session 6: Cancer Biology Identifying Unique Challenges and Opportunities in Incorporating Patient Advocates into the Lung Cancer SPORE Program Elda Railey UTSWMC/MDACC Lung SPORe and Research Advocacy Network
  • First Name: John
    Last Name: Minna
    Affiliation: UTSWMC
 Abstract_Submission.pdf No Approved to be a Speaker
Mon, 03/11/2024 - 06:48 Elliott Brea elliott_brea@dfci.harvard.edu 8479221042 Session 1: Oncogene-driven lung cancers and resistance to targeted therapies Development and effectiveness of TROP2 CAR T in EGFRm NSCLC including in TROP2 ADC refractory settings Elliott Brea DFCI
  • First Name: Eric
    Last Name: Smith
    Affiliation: DFCI
  • First Name: David
    Last Name: Barbie
    Affiliation: DFCI
  • First Name: Sachiv
    Last Name: Chakravarti
    Affiliation: DFCI
  • First Name: Alexis
    Last Name: Mottram
    Affiliation: DFCI
  • First Name: Prafulla
    Last Name: Gokhale
    Affiliation: DFCI
  • First Name: Ken
    Last Name: Ng
    Affiliation: DFCI
  • First Name: Cloud
    Last Name: Paweletz
    Affiliation: DFCI
  • First Name: Pasi
    Last Name: Jänne
    Affiliation: DFCI
  • First Name: Simon
    Last Name: Baldacci
    Affiliation: DFCI
  • First Name: Elena
    Last Name: Ivanova
    Affiliation: DFCI
  • First Name: Ha
    Last Name: Vo
    Affiliation: DFCI
  • First Name: Tran
    Last Name: Thai
    Affiliation: DFCI
  • First Name: Timothy
    Last Name: Haggerty
    Affiliation: DFCI
 Abstract_Submission.pdf No Approved to be a Poster Presenter
Mon, 03/11/2024 - 13:12 Esra Akbay esra.akbay@utsouthwestern.edu 2146484159 Session 1: Oncogene-driven lung cancers and resistance to targeted therapies Kras G12D inhibition causes tumor regression and synergizes with immune checkpoint blockade in immunogenic lung cancer models Esra Akbay UT Southwestern Medical Center Abstract_Submission.pdf No Approved to be a Poster Presenter